Research & Development
Policy & Regulation
Trends & Finance
Mergers & Acquisitions: Page 3
Video from AACC: PerkinElmer on diagnostics, acquisitions
Click on the video below for the interview.
August 1, 2022
Genetic Technologies completes AffinityDNA asset purchase
Under the terms of the agreement, Genetic Technologies has acquired all of AffinityDNA's assets including websites, brand identities, laboratory testing, and distribution agreements.
July 14, 2022
Medix Biochemica acquires U.S. diagnostic base matrix supplier
Medix said that the acquisition will enable it to provide customers with a comprehensive offering of raw materials for their IVD quality control products.
June 19, 2022
GBS to acquire drug screening firm Intelligent Fingerprinting
The acquisition would enable the combination of Intelligent Fingerprinting's sweat-based drug screening technology with the GBS saliva-based glucose biosensor platform and manufacturing expertise, GBS said.
June 15, 2022
Quidel shareholders approve $6B deal to buy Ortho
Quidel and Ortho announced the deal in December 2021, in which Quidel would acquire Ortho for an equity value of $6 billion. The deal would unite two large providers of in vitro diagnostics and has been promoted as one of the largest acquisitions in diagnostics of 2021.
May 16, 2022
Nicoya completes purchase of LSK Technologies
The deal will allow both firms to improve access to laboratory-quality testing for a variety of indications, Nicoya said.
May 1, 2022
Quest Diagnostics Q4 revenues down 15% on COVID testing but base business grew
In pilot study, liquid biopsy test differentiates between localized and metastatic cancer to inform tailored treatment
SD Biosensor, SJL Partners complete acquisition of Meridian Bioscience
Roche reports flat diagnostics revenue growth for 2022
French point-of-care testing firm Biosynex to acquire Chembio Diagnostics for $17.2M
Sherlock Biosciences acquires Sense Biodetection to drive CRISPR-based test adoption
Castle Biosciences completes $65M AltheaDx acquisition
Under the terms of the definitive agreement, AltheaDx became a subsidiary of Castle Biosciences. At closing, Castle paid $65 million to AltheaDx security holders, which consisted of $32.5 million in cash and $32.5 million in Castle common stock.
April 26, 2022
American Laboratory Products to merge with GeneProof
GeneProof is based in Brno, Czech Republic. It produces and distributes more than 70 molecular diagnostic tests -- including PCR kits and instrument platforms for such uses as nucleic acid extraction -- to clients in Europe, Africa, the Middle East, and South America.
April 21, 2022
Fulgent to acquire Inform Diagnostics
Under the agreement, Fulgent will acquire Inform Diagnostics at about $170 million, to be paid from cash on hand. The acquisition is expected to close during the second quarter of 2022, subject to closing conditions, including regulatory approvals.
April 18, 2022
LetsGetChecked to acquire Veritas Genetics and its spinoff
These acquisitions give LetsGetChecked access to whole genome sequencing, as well as targeted panels and tests such as pharmacogenomics, cancer screening, carrier screening, and maternal-fetal testing.
March 29, 2022
Pramana debuts DPaaS, inks commercial deal
To be introduced at the U.S. and Canadian Academy of Pathologists (USCAP) annual meeting in Los Angeles from March 19-24, DPaaS uses an intelligent whole-slide image acquisition system fed by a robot and analyzed by proprietary algorithms to achieve 100% real-time, fully automated assessment. A single scanning cluster is capable of scanning more than 1,000 slides per day.
March 15, 2022
PathGroup acquires Pathology Consultants
For PathGroup, the acquisition adds Pathology Consultants' existing clinical and molecular services for that company's clientele to the PathGroup family, according to a release by PathGroup.
January 23, 2022
Page 3 of 7